Annual Report

The report reported FY2016 consolidated revenue of $1,364.9 million, down 8.6%, while Life Sciences revenue grew 13.7%. A $314.0 million after-tax impairment contributed to a statutory net loss of $240.7 million. ALS described European acquisitions in food and environmental testing and a global sustainability intranet for tracking environmental indicators. It also reported an LTIFR reduction of over 40% to 1.2.